Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression
Brain, Behavior, and Immunity · 2024-08 · 120 · 248-255
DOI: 10.1016/j.bbi.2024.05.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024-08. Verfasst von Chelsea Reichert Plaska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Psychiatry Division, Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University …. Hauptthemen laut MEDLINE: Major Depressive Disorder, Microglia, Receptors, Immunologic, Membrane Glycoproteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIMH NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Major depressive disorder (MDD) is associated with Alzheimer's disease (AD) but the precise mechanisms underlying this relationship are not understood. While it is well established that cerebrospinal fluid (CSF) soluble levels of triggering receptor expressed on myeloid cells 2 (sTREM2) increase during early stages of AD, how sTREM2 levels behave in subjects with MDD is not known. In a longitudinal study, we measured CSF sTREM2 levels in 27 elderly cognitively intact individuals with late-life major depression (LLMD) and in 19 healthy controls. We tested the hypothesis that, similarly to what happens in early stages of AD, CSF sTREM2 would be elevated in MDD. In addition, we compared the associations of CSF sTREM2, pro- and anti- inflammatory, and AD biomarkers in LLMD and control subjects. Surprisingly, we found that mean CSF sTREM2 levels were significantly reduced in LLMD compared to controls. This reduction was no longer significant at the 3-year follow-up visit when depression severity improved. In addition, we found that CSF sTREM2 was associated with AD biomarkers and proinflammatory cytokines in controls but not in LLMD. These findings suggest that impaired microglia phagocytic response to AD pathology may be a novel link between MDD and AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geriatric Psychiatry Division, Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
- Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom.
- School of Psychology, Liverpool John Moores University, Liverpool, United Kingdom.
- Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA; VA Boston Cooperative Studies Program MAVERIC, VA Boston Healthcare System, Boston, MA, USA.
- Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA; Clinical Research Department, Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA.
- Department of Research & Development, Chiesi Farmaceutici, Parma, Italy.
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NIMH NIH HHS
Zitieren
APA
Reichert Plaska, C., Heslegrave, A., Bruno, D., Ramos-Cejudo, J., Han Lee, S., Osorio, R., Imbimbo, B. P., Zetterberg, H., Blennow, K., & Pomara, N. (2024). Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression. Brain, Behavior, and Immunity, 120, 248-255. https://doi.org/10.1016/j.bbi.2024.05.030
Vancouver
Reichert Plaska C, Heslegrave A, Bruno D, Ramos-Cejudo J, Han Lee S, Osorio R, et al. Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression. Brain, Behavior, and Immunity. 2024;120:248-255. doi:10.1016/j.bbi.2024.05.030
BibTeX
@article{ReichertPlaska2024,
author = {Reichert Plaska, Chelsea and Heslegrave, Amanda and Bruno, Davide and Ramos-Cejudo, Jaime and Han Lee, Sang and Osorio, Ricardo and Imbimbo, Bruno P and Zetterberg, Henrik and Blennow, Kaj and Pomara, Nunzio},
title = {Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression},
journal = {Brain, Behavior, and Immunity},
year = {2024},
volume = {120},
pages = {248--255},
doi = {10.1016/j.bbi.2024.05.030}
}
EUVIMED